Position
Creative Planning in Jazz Pharmaceuticals Plc
Back to the book · All holders of JAZZ
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $71.8K$170.01 → $189.06
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.77K | $641.1K | — | — | — | 0.0% |
| Q1 2026 | 9.2K | $1.74M | $189.06 | $71.8K | $1.03M | 0.0% |